
HCV-Related Liver Cancer in People with Hemophilia
A review of the epidemiology, risk factors, treatment, and outcomes of liver cancer associated with chronic hepatitis C infection, with
Year: 2023
Language: English
Author(s): World Federation of Hemophilia
Format: Video
This video gives a quick introduction to extended half-life (EHL) clotting factor replacement therapy.
Learn more about different treatment options for hemophilia with the World Federation of Hemophilia Shared Decision Making tool!
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

A review of the epidemiology, risk factors, treatment, and outcomes of liver cancer associated with chronic hepatitis C infection, with

Presents data on the reported use of factor VIII (FVIII) per country. FVIII use varies considerably, even among the wealthiest

An analysis of the global prevalence of hemophilia A, based in large part on the WFH’s Global Survey Data. Prevalence

As their life expectancy approaches that of the general population, people with hemophilia are now facing many of the same

A comprehensive, multidisciplinary overview of the key issues in joint replacement surgery, from pre-operative assessment to long-term management.

Also Available In: English, Spanish, French, Arabic, Russian, Simplified Chinese This is not an official WFH translation. This resource has been